Filter
407
Filtered Results: 407
Text search:
Gavi,
the
Vaccine
Alliance
Featured
Recommendations
39
New Publications
109
Language
Document type
No document type
181
Studies & Reports
107
Strategic & Response Plan
52
Guidelines
28
Manuals
19
Fact sheets
12
Situation Updates
6
Training Material
2
Countries / Regions
Global
47
Liberia
17
Sierra Leone
15
Kenya
12
Nigeria
10
Nepal
9
Africa
9
Uganda
7
Congo, Democratic Republic of
6
Ethiopia
6
Myanmar / Burma
6
South–East Asia Region
6
Western and Central Europe
6
Guinea
5
Ghana
5
Zambia
5
Bangladesh
5
Malawi
5
East and Southern Africa
5
Burkina Faso
4
Pakistan
4
Syria
4
West and Central Africa
4
Middle East and North Africa
4
Latin America and the Carribbean
4
Senegal
3
Zimbabwe
3
India
3
South Sudan
3
Cambodia
3
Asia
3
Mali
2
Somalia
2
Afghanistan
2
Tanzania
2
Rwanda
2
South Africa
2
Central African Republic
2
Namibia
2
Brazil
2
Madagascar
2
Eastern Europe and Central Asia
2
USA
1
Cameroon
1
Haiti
1
Iraq
1
Germany
1
China
1
Indonesia
1
Benin
1
Ukraine
1
Colombia
1
Botswana
1
Lesotho
1
Yemen
1
Eastern Europe
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
130
Clinical Guidelines
36
Women & Child Health
29
Public Health
21
Key Resources
9
Pharmacy & Technologies
3
Capacity Building
2
Toolboxes
COVID-19
59
Health Financing Toolbox
48
Rapid Response
25
AMR
22
Ebola
18
Global Health Education
18
Polio
16
Planetary Health
8
Pharmacy
7
HIV
6
Refugee
5
Mental Health
5
NTDs
5
Cholera
4
TB
4
Disability
3
Conflict
3
Caregiver
3
NCDs
3
Health Financing
1
Geneva, 22 May 2023 – Gavi, the Vaccine Alliance today published a roadmap* outlining critical...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to ta...
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of ... Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought together more than 300 people, including 42 Heads of State and Government. 62 countries were represented, notably 14 Gavi implementing countries, all of the G7 nations and 19 governments of the G20. Eminent participants also included H.E. Antonio Guterres, Secretary-General of the United Nations; H.E. Moussa Faki Mahamat, Chairperson of the African Union Commission; H.E. Dr Tedros Adhanom Ghebreyesus, WHO Director-General; H.E. Henrietta Fore, UNICEF Executive Director; Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation; Ministers from implementing and donor countries; CEOs of vaccine manufacturing companies and private sector partners; leaders of UN and other international agencies; senior civil society representatives; and Gavi champions. A full list of the participants can be found in Annex.
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine<...
The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this ...
The Global Action Plan for Healthy Lives and Well-being for All (SDG3 GAP) is a set of commitments by 13 multilateral agencies to strengthen their collaboration. For this purpose several accelerators were created and an invitation for public comment...
Background
Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and .... Now mid-way through the scale-up phase, the tools we need to fundamentally change the course of this pandemic are within reach. But to deliver the full impact of the ACT-Accelerator – and ultimately an exit to this global crisis – these tools need to be available everywhere. On behalf of the ACT-Accelerator Pillar lead agencies – CEPI, Gavi, the Global Fund, FIND, Unitaid, Wellcome Trust, the World Bank, and the World Health Organization, as well as the Bill & Melinda Gates Foundation – I am pleased to share this document setting out the near-term priorities, deliverables and financing requirements of the ACT-Accelerator Pillars and Health Systems Connector. Urgent action to address these financing requirements will boost the impact of the ACTAccelerator achievements to date, fast-track the development and deployment of additional game-changing tools, and mitigate the risk of a widening gap in access to COVID-19 tools between low- and high-income countries. Delivering on this promise requires strong political leadership, financial investment, and incountry capacity building. COVID-19 cannot be beaten by any one country acting alone. We must ACT now, and ACT together to end the COVID-19 crisis.
Presentations and agenda of the meeting held to update industry on the COVAX Facility and Gavi’s support for cold chain equipment (CCE) for COVID...
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vac...
L’immunisation: un chantier inachevé
recommended
Un rapport de plaidoyer de la Fédération internationale des Sociétés de la Croix-Rouge et du Croissant-Rouge
publié en partenariat avec l’Alliance mondiale pour les vaccins et l’immunisati...
Financing Global Health 2013: Transition in an Age of Austerity, IHME’s fifth annual report on global health expenditure, depicts financing trends that underline the resilience of development assistance for health. This year’s updated estimates ...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in t... darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisive role in restricting fair access to a life-saving health product. This report focuses on six leading vaccine developers, AstraZeneca, BioNTech, Johnson & Johnson, Moderna, Novavax and Pfizer, assessing each company’s human rights policy, pricing structure, records on intellectual property, knowledge and technology sharing, allocation of available vaccine doses and transparency.
Available in Arabic, English, French, German and Spanish
Since the emergence of COVID 19 in December 2019, various public health responses measures have been implemented to control the pandemic. Among measures taken by ... Africa CDC was the launch of PACT initiative to accelerate COVID 19 testing. Key to the initiative is the engagement of Community Health Workers (CHWs) in risk communication and community engagement (RCCE), surveillance activities for early case identification, contacts tracing and in facilitating referrals for testing and continuum of care.
As of 31 May 2021, Through PACT support, over 17154 CHWs have been trained and locally deployed in 24 AU Member states. The PACT supported CHWs visited more than 2,568,654 households for community engagement activities, active case search and contact tracing, identified 1,618,601 Contacts, 710,167 COVID 19 suspect cases based on the standard case definition and facilitated referrals for 553053 (78%) suspect cases for testing. These efforts were crucial for early identification and isolation of cases in limiting further transmission.
An example of integration of research into epidemic response.
